Durgam Suresh K. Insider Trades

Insider Trading History

Track insider trading activity for Durgam Suresh K.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Apr 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$26.4M 200,316 shares
$131.87
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $1.73M 13,134 shares
Last Trade
Apr 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.88M 21,876 shares
$131.87
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $5.66M 42,913 shares
Last Trade
Mar 10, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$409k 3,116 shares
$131.24
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Mar 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$964k 7,345 shares
$131.25
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $6.07M 46,029 shares
Last Trade
Mar 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$964k 7,345 shares
$131.25
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $1.73M 13,133 shares
Last Trade
Mar 06, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.72M 13,133 shares
$131.25
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $5.1M 38,684 shares
Last Trade
Mar 06, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$731k 5,572 shares
$131.19
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $5.84M 44,256 shares
Last Trade
Mar 06, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.72M 13,133 shares
$131.25
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $2.31M 17,485 shares
Last Trade
Mar 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.12M 8,742 shares
$128.20
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $4.59M 34,832 shares
Last Trade
Mar 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.12M 8,742 shares
$128.20
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $4.1M 31,123 shares
Last Trade
Mar 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$475k 3,709 shares
$128.20
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $3.25M 24,621 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.13M 24,621 shares
$127.19
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $3.44M 26,090 shares
Last Trade
Jan 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$601k 4,730 shares
$127.00
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $4.06M 30,820 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.4M 11,017 shares
$127.08
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $2.81M 21,336 shares
Last Trade
Mar 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$243k 3,712 shares
$65.59
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $3.1M 23,515 shares
Last Trade
Mar 10, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$496k 7,345 shares
$67.48
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $969k 7,345 shares
Last Trade
Mar 10, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$496k 7,345 shares
$67.48
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $2.49M 18,892 shares
Last Trade
Mar 07, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$429k 6,450 shares
$66.56
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $2.98M 22,620 shares
Last Trade
Mar 06, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$867k 13,132 shares
$66.03
$131.87
Intra-Cellular Therapies
Intra-Cellular Therapies ITCI
Evp, Chief Medical Officer
Holding Value $3.46M 26,266 shares
Last Trade
Mar 06, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$867k 13,132 shares
$66.03
$131.87

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up